NCT00905177

Predictors of Anticoagulation Control on Warfarin Therapy

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 687 (actual)
• Sponsor: University of Pennsylvania · Academic / Other
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

The goal of this research study is to develop better dosing of anticoagulation medication in both Caucasian and African Americans through analysis of various genetic factors.

Detailed description

This is a prospective cohort study among adult patients requiring warfarin therapy. Patients presenting for anticoagulation will be identified at the start of therapy and followed throughout their course until they reach maintenance dose. We will then develop a dosing equation for warfarin using patient, environmental and genetic factors.

Conditions

• Atrial Fibrillation
• Deep Vein Thrombosis
• Heart Valve Replacement

Timeline

• Start date: 2009-06-01
• Primary completion: 2013-08-01
• Completion: 2013-08-01
• First posted: 2009-05-20
• Last updated: 2016-05-20

Locations

2 sites across 1 country: United States